GXMC
PGNX

Global X Management Company’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Global X Management Company’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,831
Closed -$39K – 980
2015
Q3 		$39K Buy
+6,831
New +$52.4K ﹤0.01% 407

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Global X Management Company's PGNX Position: Q4 2015 in Review

Global X Management Company sold out of Progenics Pharmaceuticals Inc (PGNX) in Q4 2015, closing a stake of 6,831 shares — an estimated $39K sold.

Global X Management Company first reported a position in PGNX in Q3 2015 and held it in 1 quarter. The position peaked at $39K in Q3 2015. 121 funds tracked by Wall St. Rank hold PGNX as of Q4 2015.

  • Global X Management Company reported no remaining Progenics Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Global X Management Company sold 6,831 Progenics Pharmaceuticals Inc shares in Q4 2015, an estimated $39K.
  • Global X Management Company first reported a position in Progenics Pharmaceuticals Inc in Q3 2015 and held it in 1 quarter.
  • Global X Management Company's Progenics Pharmaceuticals Inc position peaked at $39K in Q3 2015.
  • 121 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q4 2015.

Based on Global X Management Company's 13F filing for Q4 2015, filed 11 Feb 2016.